News|Articles|December 9, 2024
Recap Key Industry Trends for Viral Clearance and NGS
Author(s)Charles River
Learn highlights from the 2024 event, including new strategies for viral clearance and NGS applications for viral safety testing.
Newsletter
Stay at the forefront of biopharmaceutical innovation—subscribe to BioPharm International for expert insights on drug development, manufacturing, compliance, and more.
Related Content
Trending on BioPharm International
1
FDA Clears In-Vivo Gene Editing Therapy PBGENE-DMD for Duchenne Trial
2
The Clinical Execution Gap: Why Great Science Often Fails at the Trial Stage
3
Preclinical Study Finds Subcutaneous Nanotrastuzumab Comparable to Herceptin HYLECTA in Minipig Model
4
VectorY Doses First Patient in TDP-43–Targeting ALS Trial
5